In NB, deletion of the RUNX3 locus is commonly observed in aggressive NBs, especially in those with MYCN amplification, implicating that loss of RUNX3 expression might be related to tumorigenesis and progression in NB. The gene discussed is RUNX3; the disease is neuroblastoma.